drug-eluting stents 中文意思是什麼
drug-eluting stents
解釋
藥物釋放支架-
Progress in application of drug - eluting stents in prevention and treatment of restenosis
藥物洗脫支架防治再狹窄的研究進展 -
The stated purpose of the fda meeting is to weigh the risks and benefits of drug - eluting stents
Fda會議的目的就是衡量藥物包衣支架系統的利弊。 -
An estimated 6 million people worldwide hae receied drug - eluting stents, 3 million of them in the united states
估計全球有6百萬人接受了藥物洗脫支架,其中3百萬人在美國。 -
But recent eidence suggests that drug - eluting stents carry a risk of producing potentially dangerous blood clots
但是最近的證據顯示藥物洗脫支架具有潛在的導致血液凝集的危險性。 -
Drug - eluting stents were introduced three years ago and hae now become dominant tools in the field of cardioascular surgery
藥物洗脫支架在三年前提出,現在已經成為心血管手術領域的主要工具。 -
But some doctors use drug - eluting stents, as they are called, for patients with more serious heart problems
但也有許多醫生使用藥物洗脫支架,正如其名,這類支架用於患有更為嚴重的心臟疾病的患者。 -
On the other hand, restenosis deeloped in 47 % of patients, ersus reported rates of 28 % for bare metal stents and 6 % after drug - eluting stents
另一方面, 47 %的患者出現了再狹窄,而應用裸支架的患者再狹窄發生率據報道是28 % ,而應用塗層支架的是6 % 。 -
New evidence is emerging to contradict earlier claims that drug - eluting stents cause increased risks for patients, although nice ' s recent preliminary guidance was against their use in coronary artery disease
藥物洗脫支架早前曾有藥物洗脫支架會導致病人風險增加的說法, nice近期發布的初步指南也反對在冠狀動脈疾病中使用藥物洗脫支架,但已有新證據結論與此相反。 -
New york ( reuters health ), feb 13 - ahead of its scheduled publication date of march 8, the new england journal of medicine has released fie original articles and two editorials regarding the risk and benefits of drug - eluting stents for treatment of coronary artery stenosis
紐約(路特健康) 2月13日- - - 《新英格蘭醫學》雜志比計劃出版日期3月8日提前報道了關于使用藥物洗脫支架治療冠狀動脈狹窄好壞的5篇研究原文和2篇社論。 -
Thus, restricting the use of drug - eluting stents to patients in stable condition with noncomplex coronary stenoses is likely to reduce the risk of late stent thrombosis
因此,病人病情穩定並且沒有復雜的冠狀動脈狹窄時限定病人使用藥物洗脫支架很有可能降低潛在的支架血栓形成風險性。 -
Background : estradiol promotes rapid re - endothelialization of coronary stents in animal models, but it is not known whether combining this drug with rapamycin represents an improed drug - eluting stent technology in terms of reduced lumen renarrowing
背景:動物實驗中,雌二醇可以促進冠脈支架的快速再內皮化,但是聯合應用雌二醇和雷帕黴素的藥物洗脫支架是否在減少管腔再狹窄方面更加有效,尚不得而知。
分享友人